A roundup of this week’s Funding Insight articles
This week we learn how AstraZeneca will be opening its doors—and its wallet—to a select few postdocs, we get a lesson on how to approach intellectual property discussions, we learn about a scheme investigating the changing political shape of Europe and, finally, we eye up the trials on the road to the holy grail of impact: policy change.
This week in Funding Insight